NCT04734795 The Prevalence of Dysfunctional Breathing in Children and Adolescents With Asthma Status COMPLETED Phase N/A
NCT04728191 The Effect of Physiotherapy on Dysfunctional Breathing in Children and Adolescents With and Without Asthma Status UNKNOWN Phase NA
NCT04724733 Promoting Risk Reduction Among Young Adults With Asthma During Wildfire Smoke Events (TRAK) Status COMPLETED Phase NA
NCT04724278 Measuring Omalizumab Responses Using Real-world Evidence (MORRE) Study Status UNKNOWN Phase N/A
NCT04719832 Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype Status COMPLETED Phase PHASE3
NCT04718389 A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype Status COMPLETED Phase PHASE3
NCT04718103 A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype Status COMPLETED Phase PHASE3
NCT04716023 Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19 Status UNKNOWN Phase N/A
NCT04706988 Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma Status RECRUITING Phase N/A
NCT04696965 Appropriate Inhaler Use of Tiotropium As Add-on Therapy in Symptomatic Asthma Status COMPLETED Phase NA
NCT04684966 Combined Neuromuscular Electrical Stimulation for Quadriceps and Triceps During Pulmonary Rehabilitation in COPD Status COMPLETED Phase NA
NCT04677959 A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma Status COMPLETED Phase PHASE4
NCT04673630 Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma Status COMPLETED Phase PHASE1
NCT04669288 AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department Status TERMINATED Phase PHASE3
NCT04665895 A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma Status COMPLETED Phase PHASE3
NCT04665141 Similarities and Differences of Biological Therapies for Severe Asthma. Status UNKNOWN Phase N/A